We are live on !
Find out more
Tocqueville Asset Management Portfolio holdings
AUM
$7.56B
Turnover
9.98%
1-Year Est. Return
44.87%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$8.39B
AUM Growth
+$843M
(+11%)
Cap. Flow
+$145M
Cap. Flow % of AUM
Cap. Flow %
1.72%
Top 10 Holdings %
Top 10 Hldgs %
16.86%
Holding
955
New
85
Increased
253
Reduced
342
Closed
109
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franco-Nevada
FNV
|
+$78.7M |
| 2 |
GG
Goldcorp Inc
GG
|
+$30.2M |
| 3 |
Agnico Eagle Mines
AEM
|
+$30.2M |
| 4 |
Williams-Sonoma
WSM
|
+$22.4M |
| 5 |
SLB Ltd
SLB
|
+$16.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gold Fields
GFI
|
+$40.9M |
| 2 |
GG.WS.A
GOLDCORP INC SERIES A WARRANTS EXP 5/30/2007
GG.WS.A
|
+$31.7M |
| 3 |
McDonald's
MCD
|
+$18.4M |
| 4 |
EMC CORPORATION
EMC
|
+$17.8M |
| 5 |
SYT
Syngenta Ag
SYT
|
+$8.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 20.65% |
| 2 | Miscellaneous | 15.52% |
| 3 | Healthcare | 11.92% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Technology | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Marriott International
MAR
$101B
| $1.81M | 0.02% |
27,225
-3,886
| -12% | -$261K |
2014 Q4
6 quarters
|
|
377
Jazz Pharmaceuticals
JAZZ
$13.6B
| $1.76M | 0.02% |
12,450
+8,750
| +236% | +$1.29M |
2016 Q1
1 quarter
|
|
|
STJ
378
DELISTED
St Jude Medical
STJ
| $1.75M | 0.02% |
22,468
-1,482
| -6% | -$106K |
2013 Q2
12 quarters
|
|
379
iShares Preferred and Income Securities ETF
PFF
$12B
| $1.75M | 0.02% |
43,871
-2,370
| -5% | -$92.9K |
2014 Q4
6 quarters
|
|
380
Enterprise Products Partners
EPD
$79.5B
| $1.75M | 0.02% |
59,771
+1,241
| +2% | +$33.3K |
2013 Q2
12 quarters
|
|
|
TWTR
381
DELISTED
Twitter, Inc.
TWTR
| $1.74M | 0.02% |
103,150
| – | – |
2013 Q4
10 quarters
|
|
382
DexCom
DXCM
$32.5B
| $1.72M | 0.02% |
86,780
+25,200
| +41% | +$429K |
2013 Q2
12 quarters
|
|
383
Rio Tinto
RIO
$147B
| $1.72M | 0.02% |
54,822
+1,043
| +2% | +$31.1K |
2016 Q1
1 quarter
|
|
|
KITE
384
DELISTED
Kite Pharma, Inc.
KITE
| $1.71M | 0.02% |
34,250
-600
| -2% | -$29.5K |
2014 Q4
6 quarters
|
|
|
LNKD
385
DELISTED
LinkedIn Corporation
LNKD
| $1.7M | 0.02% |
8,960
-10,373
| -54% | -$1.44M |
2013 Q2
12 quarters
|
|
386
Netflix
NFLX
$294B
| $1.69M | 0.02% |
185,150
-584,000
| -76% | -$5.61M |
2015 Q3
3 quarters
|
|
387
Acadia Healthcare
ACHC
$2.79B
| $1.68M | 0.02% |
30,350
+2,300
| +8% | +$135K |
2015 Q1
5 quarters
|
|
388
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.68M | 0.02% |
289,340
-10,175
| -3% | -$64.8K |
2013 Q2
12 quarters
|
|
389
Templeton Dragon Fund
TDF
$235M
| $1.67M | 0.02% |
96,415
-21,365
| -18% | -$362K |
2014 Q4
6 quarters
|
|
|
BCR
390
DELISTED
CR Bard Inc.
BCR
| $1.66M | 0.02% |
7,072
+124
| +2% | +$26.9K |
2013 Q2
12 quarters
|
|
391
Ducommun
DCO
$2.58B
| $1.65M | 0.02% |
+83,200
| New | +$1.42M |
2016 Q2
0 quarters
|
|
392
Ligand Pharmaceuticals
LGND
$5.89B
| $1.62M | 0.02% |
21,841
-2,260
| -9% | -$168K |
2013 Q2
12 quarters
|
|
393
Sibanye-Stillwater
SBSW
$7.15B
| $1.62M | 0.02% |
+126,553
| New | +$1.61M |
2016 Q2
0 quarters
|
|
394
Masco
MAS
$14.4B
| $1.62M | 0.02% |
52,354
+2,500
| +5% | +$78.9K |
2013 Q2
12 quarters
|
|
|
VMW
395
DELISTED
VMware, Inc
VMW
| $1.6M | 0.02% |
28,050
| – | – |
2013 Q2
12 quarters
|
|
396
Criteo S.A.
CRTO
$752M
| $1.59M | 0.02% |
34,600
| – | – |
2016 Q1
1 quarter
|
|
397
HCA Healthcare
HCA
$99.3B
| $1.58M | 0.02% |
20,530
-1,925
| -9% | -$152K |
2013 Q2
12 quarters
|
|
|
SSI
398
DELISTED
Stage Stores Inc
SSI
| $1.56M | 0.02% |
+318,705
| New | +$1.98M |
2016 Q2
0 quarters
|
|
399
Toyota
TM
$229B
| $1.53M | 0.02% |
15,300
-1,765
| -10% | -$181K |
2014 Q2
8 quarters
|
|
400
iShares US Real Estate ETF
IYR
$4.18B
| $1.52M | 0.02% |
18,460
-685
| -4% | -$53.7K |
2014 Q4
6 quarters
|
|
Similar funds
Tocqueville Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Tocqueville Asset Management held 955 positions worth $8.39B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Tocqueville Asset Management's Q2 2016 filing shows 85 new, 253 increased, 342 reduced and 109 closed positions. Its largest new stake was Marathon Petroleum: 344,692 shares worth $13.1M. The largest sale was Gold Fields, an estimated $40.9M.
By sector, the portfolio is most concentrated in Materials at 21% of assets, up from 16% a quarter earlier, followed by Miscellaneous and Healthcare.
- Tocqueville Asset Management's largest Q2 2016 buy was Marathon Petroleum: 344,692 shares worth $13.1M.
- Tocqueville Asset Management added most to Franco-Nevada in Q2 2016, an estimated $78.7M increase.
- Tocqueville Asset Management's biggest Q2 2016 reduction was Gold Fields, cutting an estimated $40.9M.
- Tocqueville Asset Management fully exited GOLDCORP INC SERIES A WARRANTS EXP 5/30/2007 in Q2 2016, selling an estimated $31.7M.
- Tocqueville Asset Management's ten largest holdings make up 17% of its $8.39B portfolio in Q2 2016.
- Tocqueville Asset Management opened 85 new positions and closed 109 in Q2 2016.
- Tocqueville Asset Management's portfolio value rose 11% quarter-over-quarter to $8.39B.
Based on Tocqueville Asset Management's 13F filing for Q2 2016, filed 29 Jul 2016.